A drug that dissociates slowly from the target and rapidly from off-target proteins has kinetic selectivity. If this results in prolonged activity after the drug has been eliminated then this would enable less frequent dosing and a widening of the therapeutic window. The translation of extended target occupancy to prolonged activity depends on target vulnerability and the rate of protein synthesis for both inhibitors and degraders…
